Published Date: 04 Mar 2023
Karnataka: Karnataka Examination Authority (KEA) yog PG AYUSH ...
Read Full NewsThe U.S. Food and Drug Administration has declined to approve Achieve Life Sciences' drug to treat nicotine dependence in adults, citing unresolved issues found at a...
The profession has always attracted perfectionists. Experts worry a more fear-based version of the trait could affect both doctors and patients.
Rucaparib maintenance delays both first and second subsequent therapies among patients with advanced ovarian cancer.
1.
Only 1 in 4 Eligible Adults Receive Lung Screening
2.
Australian researchers attribute drop in melanoma rates to increasingly diverse population
3.
Acalabrutinib + Venetoclax Combo Earns FDA Nod for CLL
4.
Finding a clue to the origin of treatment-resistant leukemia in kids
5.
Aster Whitefield Hospital, with 506 beds, opened.
1.
Cutting-Edge Cancer Care: The Precision Revolution in Surgical Oncology
2.
A Closer Look at MCV Modules: Features, Functions, and Benefits
3.
Unlocking the Secrets of Neutrophils: Exploring Their Role in Immune Defense
4.
The Significance of APTT Blood Test Results for Detecting Coagulation Disorders
5.
General Practitioners Role in Diagnosing Ovarian Cancer
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
International Lung Cancer Congress®
1.
Exploring Potentials of Lorlatinib: The Third Generation ALK-TKI Through CROWN Trial
2.
Navigating the Complexities of Ph Negative ALL - Part VII
3.
From Relapse to Remission: Mapping the Treatment Journey in Adult R/R-Cell ALL - Part 2
4.
Navigating the Complexities of Ph Negative ALL - Part I
5.
Current Scenario of Cancer- Q&A Session to Close the Gap Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation